LGN Stock - Legence Corp. Class A Common stock
Unlock GoAI Insights for LGN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $2.10B | $1.62B | $1.25B |
| Gross Profit | $428.64M | $315.15M | $233.71M |
| Gross Margin | 20.4% | 19.5% | 18.7% |
| Operating Income | $58.44M | $10.26M | $-24,248,000 |
| Net Income | $9.72M | $-46,026,000 | $-82,274,000 |
| Net Margin | 0.5% | -2.8% | -6.6% |
| EPS | $0.10 | $-0.45 | $-0.81 |
Legence Corp. provides engineering, installation, and maintenance services for mission-critical systems in buildings in United States. The company operates through two segments, Engineering & Consulting, and Installation & Maintenance. The Engineering & Consulting segment designs HVAC and other MEP systems for buildings, develops strategies to help reduce energy usage and make buildings more sustainable and provides program and project management services for client's installation and retrofit projects. It offers engineering and design, and program and project management services. The Installation & Maintenance segment fabricates and installs HVAC systems, process piping and other MEP systems in new and existing industrial, commercial and institutional buildings and provides ongoing preventative and corrective maintenance services for those systems. The company serves data centers, semiconductors, precision manufacturing, life sciences, healthcare, education, and commercial real estate industries, as well as public sector. The company was founded in 1914 and is based in San Jose, California.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 18th 2025 | Jefferies | Upgrade | Buy | $49 |
| October 24th 2025 | Roth Capital | Initiation | Buy | $41 |
| October 7th 2025 | Goldman | Initiation | Buy | $37 |
| October 7th 2025 | BMO Capital Markets | Initiation | Outperform | $36 |
| October 7th 2025 | Bernstein | Initiation | Outperform | $38 |
| October 7th 2025 | Jefferies | Initiation | Hold | $34 |
| October 7th 2025 | Rothschild & Co Redburn | Initiation | Buy | $35.5 |
| October 7th 2025 | RBC Capital Mkts | Initiation | Outperform | $36 |
| October 7th 2025 | Stifel | Initiation | Buy | $36 |
| October 7th 2025 | BTIG Research | Initiation | Buy | $40 |
| October 7th 2025 | Wolfe Research | Initiation | Outperform | $40 |
| October 7th 2025 | BofA Securities | Initiation | Buy | $35 |
Earnings History & Surprises
LGNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | $0.08 | $-0.02 | -124.1% | ✗ MISS |
Latest News
Stifel Maintains Buy on Legence, Raises Price Target to $50
📈 PositiveLegence shares are trading lower after the company announced a secondary offering of 7 million Class A shares.
📉 NegativeLegence Announces Secondary Underwritten Public Offering Of 7M Shares Of Class A Common Stock
➖ NeutralTigress Financial Initiates Coverage On Legence with Buy Rating, Announces Price Target of $54
📈 PositiveLegence shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $39 to $49.
📈 PositiveStifel Maintains Buy on Legence, Raises Price Target to $47
📈 PositiveJefferies Upgrades Legence to Buy, Raises Price Target to $49
📈 PositiveBarclays Maintains Equal-Weight on Legence, Raises Price Target to $37
➖ NeutralGoldman Sachs Maintains Buy on Legence, Raises Price Target to $46
📈 PositiveRBC Capital Maintains Outperform on Legence, Raises Price Target to $48
📈 PositiveBMO Capital Maintains Outperform on Legence, Raises Price Target to $46
📈 PositiveBTIG Maintains Buy on Legence, Raises Price Target to $45
📈 PositiveLegence Sees FY2026 Sales $2.650B-$2.850B vs $2.631B Est
📈 PositiveLegence Sees Q4 Sales $600.000M-$630.000M vs $608.446M Est
➖ NeutralLegence Q3 EPS $(0.02) Misses $0.06 Estimate, Sales $708.006M Beat $639.776M Estimate
➖ NeutralLegence To Acquire Bowers For Consideration Of ~$475M; Says Over 12 Months Ended Sept. 30, Bowers Generated $767M In Total Revenue
📈 PositiveRoth Capital Initiates Coverage On Legence with Buy Rating, Announces Price Target of $41
📈 PositiveGuggenheim Initiates Coverage On Legence with Buy Rating, Announces Price Target of $41
📈 PositiveBarclays Initiates Coverage On Legence with Equal-Weight Rating, Announces Price Target of $34
➖ NeutralCantor Fitzgerald Initiates Coverage On Legence with Overweight Rating, Announces Price Target of $40
📈 PositiveFrequently Asked Questions about LGN
What is LGN's current stock price?
What is the analyst price target for LGN?
What sector is Legence Corp. Class A Common stock in?
What is LGN's market cap?
Does LGN pay dividends?
Similar Stocks
Industrials SectorExplore stocks similar to LGN for comparison